OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
Moamen M. Elmassry, Jane A. Colmer‐Hamood, Jonathan Kopel, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 916-916
Open Access | Times Cited: 23

Showing 23 citing articles:

Cystic fibrosis
Marcus Mall, Pierre–Régis Burgel, Carlo Castellani, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 24

The virulence trait and genotype distribution amongst the Pseudomonas aeruginosa clinical strains
Xiaohuan Wang, Kaijing Gao, Baishen Pan, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access

Global health perspectives on antibacterial drug discovery and the preclinical pipeline
Ursula Theuretzbacher, Ravindra P. Jumde, Alan J. Hennessy, et al.
Nature Reviews Microbiology (2025)
Closed Access

Mycobacterium abscessus Virulence Factors: An Overview of Un-Explored Therapeutic Options
Mario Cocorullo, Alessandro Stamilla, Deborah Recchia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3247-3247
Open Access

Healthcare-Associated Infections: The Role of Microbial and Environmental Factors in Infection Control—A Narrative Review
A Sandu, Mariana Carmen Chifiriuc, Corneliu Ovidiu Vrâncianu, et al.
Infectious Diseases and Therapy (2025)
Open Access

The global resistance problem and the clinical antibacterial pipeline
Ursula Theuretzbacher
Nature Reviews Microbiology (2025)
Closed Access

Effect of Matricaria aurea Essential Oils on Biofilm Development, Virulence Factors and Quorum Sensing-Dependent Genes of Pseudomonas aeruginosa
Haitham Qaralleh, Sultan Ayesh Mohammed Saghir, Muhamad O. Al-limoun, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 386-386
Open Access | Times Cited: 4

Efficacy of a Pseudomonas aeruginosa serogroup O9 vaccine
Dina A. Moustafa, Antonio DiGiandomenico, Vishnu Raghuram, et al.
Infection and Immunity (2023) Vol. 91, Iss. 12
Open Access | Times Cited: 9

Optimizing Antimicrobial Peptide Design: Integration of Cell-Penetrating Peptides, Amyloidogenic Fragments, and Amino Acid Residue Modifications
Sergey V. Kravchenko, Pavel A. Domnin, Sergei Y. Grishin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6030-6030
Open Access | Times Cited: 2

Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response
Rhea Nickerson, Christina S. Thornton, Brent Johnston, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment
Jian Yang, Jin‐Fu Xu, Shuo Liang
Critical Reviews in Microbiology (2024), pp. 1-19
Closed Access | Times Cited: 2

Current Progress in the Development of mRNA Vaccines Against Bacterial Infections
А. Н. Хлебникова, Anna Kirshina, N. A. Zakharova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13139-13139
Open Access | Times Cited: 1

The Iron Chelator, DIBI, Reduces Bacterial Load and Inflammation in Experimental Lung Infection
Xiyang Zhang, Rhea Nickerson, Lauren Burton, et al.
(2024)
Open Access | Times Cited: 1

Phage–Antibiotic Combination Therapy against Recurrent Pseudomonas Septicaemia in a Patient with an Arterial Stent
Ulla Otava, Laura Tervo, Riikka Havela, et al.
Antibiotics (2024) Vol. 13, Iss. 10, pp. 916-916
Open Access | Times Cited: 1

Therapeutic potential of Pseudomonas aeruginosa-mannose sensitive hemagglutinin (PA-MSHA) in cancer treatment
Xun Zheng, Yiqiao Fang, Xiuhe Zou, et al.
Microbial Pathogenesis (2023) Vol. 185, pp. 106422-106422
Closed Access | Times Cited: 3

The Hydroxypyridinone Iron Chelator DIBI Reduces Bacterial Load and Inflammation in Experimental Lung Infection
Xiyang Zhang, Rhea Nickerson, Lauren Burton, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1452-1452
Open Access

Microbiology and Antimicrobial Resistance in Diabetic Foot Infections
Humam Emad Rajha, Raneem Alsheikh, Amna Zar, et al.
IntechOpen eBooks (2024)
Open Access

Efficacy of aPseudomonas aeruginosaSerogroup O9 Vaccine
Dina A. Moustafa, Antonio DiGiandomenico, Vishnu Raghuram, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top